Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,206 recalls · Class II, newest first

Class II · Moderate risk

Influenzinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1131-2022
Class II · Moderate risk

Diphtherinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1130-2022
Class II · Moderate risk

Colibacillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1129-2022
Class II · Moderate risk

Anthracinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1125-2022
Class II · Moderate risk

Zonisamide Capsules USP

CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Terminated Microbial contamination Direct Rx NDC 61919-775-90 D-0888-2022
Class II · Moderate risk

Alcohol Antiseptic 80%

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Ongoing cGMP deviation A.P. Nonweiler D-1142-2022
Class II · Moderate risk

Myers Cocktail

Lack of assurance of sterility.

Completed Sterility / contamination Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0088-10 D-0938-2022

Recalls by year